Veterinary Medicines

Tilmovet 300 mg/ml Solution for Injection for cattle and sheep

Authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
Tilmovet 300 mg/ml Solution for Injection for cattle and sheep
Tilmovet 300 mg/ml Oplossing voor injectie
Tilmovet 300 mg/ml Solution injectable
Tilmovet 300 mg/ml Injektionslösung
Active substance:
  • Tilmicosin
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Tilmicosin
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        70
        day
      • Milk
        36
        day
    • Sheep
      • Meat and offal
        42
        day
      • Milk
        18
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • 100 ml Type II amber glass vial sealed with Type I bromobutyl stopper and aluminium cap, supplied in cardboard box. One vial per box.
  • 50 ml Type II amber glass vial sealed with Type I bromobutyl stopper and aluminium cap, supplied in cardboard box. One vial per box.
  • 25 ml Type I amber glass vial sealed with Type I bromobutyl stopper and aluminium cap, supplied in cardboard box. One vial per box.
  • 250 ml Type II amber glass vial sealed with Type I bromobutyl stopper and aluminium cap, supplied in cardboard box. One vial per box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0405/001
Concerned member states:
  • Belgium
  • Bulgaria
  • France
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/05/2025
Download
Dutch (PDF)
Published on: 22/10/2025
Download
French (PDF)
Published on: 22/10/2025
Download
German (PDF)
Published on: 22/10/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/10/2025
Download
French (PDF)
Published on: 22/10/2025
Download
German (PDF)
Published on: 22/10/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/10/2025
Download
French (PDF)
Published on: 22/10/2025
Download
German (PDF)
Published on: 22/10/2025
Download

Combined File of all Documents

English (PDF)
Published on: 11/05/2025
Download